Cite
Liu D, Hou X, Wu W, et al. Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer. Cell Death Dis. 2021;12(8):789doi: 10.1038/s41419-021-04073-0.
Liu, D., Hou, X., Wu, W., Zanfagnin, V., Li, Y., Correia, C., Zhao, Z., Zhao, C., Liu, Z., Zhang, T., Fang, Z., Wang, H., Xu, C., Weroha, S. J., Kaufmann, S. H., & Dai, H. (2021). Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer. Cell death & disease, 12(8), 789. https://doi.org/10.1038/s41419-021-04073-0
Liu, Dongyan, et al. "Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer." Cell death & disease vol. 12,8 (2021): 789. doi: https://doi.org/10.1038/s41419-021-04073-0
Liu D, Hou X, Wu W, Zanfagnin V, Li Y, Correia C, Zhao Z, Zhao C, Liu Z, Zhang T, Fang Z, Wang H, Xu C, Weroha SJ, Kaufmann SH, Dai H. Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer. Cell Death Dis. 2021 Aug 12;12(8):789. doi: 10.1038/s41419-021-04073-0. PMID: 34385422; PMCID: PMC8361168.
Copy
Download .nbib